Researchers from University of Arizona present a new therapeutic target to shield nerve cells from the damage of ALS.

A newly identified experimental compound, XL20, has demonstrated neuroprotective effects in mouse models and human motor ...

A new study reveals experimental drug XL20 crosses the blood-brain barrier to stop toxic TDP-43 clumping in ALS.

Amyotrophic Lateral Sclerosis, or ALS, received widespread awareness in the summer of 2014 thanks to an Ice Bucket Challenge. Millions of people participated in the challenge, drenching themselves in ...

Amyotrophic lateral sclerosis (ALS) received widespread attention in the summer of 2014 thanks to the Ice Bucket Challenge. Millions of people participated, drenching themselves in ice-cold water to ...

A review from five studies has found no added benefit of using Daiichi Sankyo’s Radicava (edaravone) and Sanofi’s Rilutek ...

Trends in the identification and treatment of ALS are expected to lead to a significant increase in clinic demand over the ...

Genetic ALS testing may sharply increase specialized clinic visits as more relatives learn their carrier status. Projected gene-related ALS cases and asymptomatic carriers may nearly triple in the U.S ...

The Waterville City Council approved a pilot program Tuesday that will allow Fire Department paramedics to provide medication ...

Adam Mosseri wants AI to give users a sense of control over recommendations. Adam Mosseri wants AI to give users a sense of control over recommendations. is a senior reporter covering technology, ...

Sarah Bradley is a writer with six years of experience creating personal essays, reported features, and content related to health and parenting topics. Nicholas R. Metrus, MD, is a neurologist and ...

WASHINGTON — In a bustling ballroom in an upscale hotel, Laura Friedman, 23, sat onstage to talk about her sex life. Specifically, sexual dysfunction. The Vanderbilt University senior explained that ...